您的位置: 首页 > 农业专利 > 详情页

Humanized anti-CCR7 receptor antibodies
专利权人:
PepMab B.V.
发明人:
Jaap Willem Back,Ronald Boshuizen,Wouter Cornelis Puijk,Johan Turkstra
申请号:
US15751169
公开号:
US20180237529A1
申请日:
2016.08.10
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention provides novel humanized anti-human CCR7 antibodies and compositions comprising such antibodies. The antibodies and compositions are useful in the treatment of a cancer of which the tumour cells express a CCR7 receptor, in the treatment of inflammatory conditions, conditions or complications arising from tissue or organ transplantations, and conditions or complications arising from or associated with fibrosis. The invention further provides nucleic acid molecules encoding the anti-CCR7 antibodies, cells expressing the anti-CCR7 antibodies and methods for producing the anti-CCR7 antibodies.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充